Vertex and CRISPR Therapeutics Partner on Gene Therapy for Blood Disorders – BioPharm International
Labiotech.eu |
Vertex and CRISPR Therapeutics Partner on Gene Therapy for Blood Disorders
BioPharm International "The addition of CTX001 to our clinical development pipeline provides us with a near-term opportunity to generate the first proof-of-concept clinical data for a CRISPR/Cas9-based medicine in two genetic diseases that are highly aligned with our … CRISPR Therapeutics Plans First CRISPR/Cas9 Clinical Trial in Europe for 2018 |
